-- Patency and host cell remodeling of the HAV were observed in all study implants – -- Preclinical study is...
● Revenue Surpassed $1 million for Nine Months of 2021 Compared to $0 for the Same Period 2020 ● Gross Margin of 48%...
MILAN, Italy and NEW YORK, Nov. 16, 2021 (GLOBE NEWSWIRE) -- Genenta Science, a clinical-stage biotechnology company pioneering the development of...
- Revenue of $2.9 million in quarter was second highest in company’s history and highest level in over two years....
Investigational therapeutics injected via the SCS Microinjector® demonstrate positive clinical data in wet AMD, diabetic retinopathy, and choroidal melanoma in...
Interim data update at SITC for ongoing ACTengine® IMA203 trial targeting PRAME demonstrated clinical responses across multiple solid tumor types...
New research from HOOPP and Common Wealth makes business case for better workplace retirement plansTORONTO, Nov. 16, 2021 (GLOBE NEWSWIRE)...
CAMBRIDGE, Mass., Nov. 16, 2021 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a gene therapy company developing life-changing treatments...
Positive trend observed in transfusion-dependent subjects treated with higher dose tovinontrine for reduced transfusion burden Tovinontrine was generally well-tolerated in this...
ADMA Now Collects Plasma from Six Vertically Integrated Centers with Three Additional Facilities Under ConstructionRAMSEY, N.J. and BOCA RATON, Fla....
OCALA, Fla., Nov. 16, 2021 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) announces financial results for the third...
VASCEPA/VAZKEPA found in prespecified and post hoc analyses to reduce total ischemic events by 32% in patients with prior PADDUBLIN,...
Net Income Up 137%, EBITDA up 136% Year Over Year. Gross Margins Jump to 30% as Third-Party Services and Testing...
Company is Scheduled to Conduct Pre-IND Meeting with the U.S. FDA Later This Month and Potentially Initiate Phase 1/2 Clinical Trial of...
Third Quarter Revenues of $6.4 Million; Year-to-Date 2021 Revenues Increased 21% Clarity on Regulatory Pathway for Resubmission of NexoBrid BLA,...
The largest and most important Psychedelic Medicine Conference in the Southern HemisphereVancouver, British Columbia--(Newsfile Corp. - November 16, 2021) -...
Toronto, Ontario--(Newsfile Corp. - November 16, 2021) - Leveljump Healthcare Corp. (TSXV: JUMP) (OTCQB: JMPHF) (FSE: 75J) ("Leveljump" or the...
With a Focus on Bringing the KARE Phase II a/b Trial (Ketamine-Assisted Psychotherapy for Alcohol Use Disorder) into Phase IIIToronto,...
This transaction strengthens Alira Health’s commitment to humanize healthcare FRAMINGHAM, Mass.--(BUSINESS WIRE)--#ai--Alira Health (http://www.alirahealth.com/), a global health care consultancy, announced...
Building on Prophecy’s Legacy of Success, New System Offers Surgeons Fewer Steps, More Efficiency MAHWAH, N.J.--(BUSINESS WIRE)--Stryker today launched the...